The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The Federal Trade Commission is accusing three companies of artificially inflating insulin list prices. We have new developments on a deadly Israeli strike in Lebanon. The Food & Drug Administration ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
13hon MSN
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Health-care company stocks fell as U.S. regulators look to crack down on prices and companies battle over market share of popular drugs. The Federal Trade Commission sued the drug middlemen that ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback